CheilanthifolineCAS# 483-44-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 483-44-3 | SDF | Download SDF |
| PubChem ID | 440582 | Appearance | Powder |
| Formula | C19H19NO4 | M.Wt | 325.36 |
| Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C5=C(C=C4)OCO5)O | ||
| Standard InChIKey | FVXCQULKSPVRPK-HNNXBMFYSA-N | ||
| Standard InChI | InChI=1S/C19H19NO4/c1-22-18-7-12-4-5-20-9-14-11(2-3-17-19(14)24-10-23-17)6-15(20)13(12)8-16(18)21/h2-3,7-8,15,21H,4-6,9-10H2,1H3/t15-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Cheilanthifoline has anti-osteoclastogenic property, it gives significant inhibitions on receptor activator of nuclear factor-κB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts. 2. Cheilanthifoline shows promising in vitro antiplasmodial activities against Plasmodium falciparum. |
| Targets | NF-kB | Antifection |
Cheilanthifoline Dilution Calculator
Cheilanthifoline Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0735 mL | 15.3676 mL | 30.7352 mL | 61.4704 mL | 76.838 mL |
| 5 mM | 0.6147 mL | 3.0735 mL | 6.147 mL | 12.2941 mL | 15.3676 mL |
| 10 mM | 0.3074 mL | 1.5368 mL | 3.0735 mL | 6.147 mL | 7.6838 mL |
| 50 mM | 0.0615 mL | 0.3074 mL | 0.6147 mL | 1.2294 mL | 1.5368 mL |
| 100 mM | 0.0307 mL | 0.1537 mL | 0.3074 mL | 0.6147 mL | 0.7684 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (-)-Isocorypalmine
Catalog No.:BCN2723
CAS No.:483-34-1
- Cephaeline
Catalog No.:BCC8143
CAS No.:483-17-0
- Dihydroberberine
Catalog No.:BCN2573
CAS No.:483-15-8
- 9-Hydroxycalabaxanthone hydrate
Catalog No.:BCC5325
CAS No.:483-14-7
- Isorauhimbine
Catalog No.:BCN5578
CAS No.:483-09-0
- Ajmalicine
Catalog No.:BCN5577
CAS No.:483-04-5
- 14-Dehydrobrowniine
Catalog No.:BCN8109
CAS No.:4829-56-5
- Tetrahydroamentoflavone
Catalog No.:BCN5571
CAS No.:48236-96-0
- RG 108
Catalog No.:BCC1134
CAS No.:48208-26-0
- Aricine
Catalog No.:BCN5576
CAS No.:482-91-7
- Indigo
Catalog No.:BCN1091
CAS No.:482-89-3
- Dalbergin
Catalog No.:BCN7452
CAS No.:482-83-7
- Sphondin
Catalog No.:BCN5579
CAS No.:483-66-9
- Toddalolactone
Catalog No.:BCN2393
CAS No.:483-90-9
- Calycanthoside
Catalog No.:BCN5580
CAS No.:483-91-0
- Luvangetin
Catalog No.:BCN7527
CAS No.:483-92-1
- SB-674042
Catalog No.:BCC1931
CAS No.:483313-22-0
- Purmorphamine
Catalog No.:BCC3641
CAS No.:483367-10-8
- N4-Benzoyl-2'-deoxycytidine
Catalog No.:BCC9071
CAS No.:4836-13-9
- N-Demethylloine
Catalog No.:BCN2004
CAS No.:4839-19-4
- Chrysophanol 1-glucoside
Catalog No.:BCC8146
CAS No.:4839-60-5
- Osthol
Catalog No.:BCN5581
CAS No.:484-12-8
- Osthenol
Catalog No.:BCN8342
CAS No.:484-14-0
- 9-Phenanthrol
Catalog No.:BCC7989
CAS No.:484-17-3
Antiplasmodial agents from the Bhutanese medicinal plant Corydalis calliantha.[Pubmed:19496064]
Phytother Res. 2010 Apr;24(4):481-5.
The alkaloidal components of the Bhutanese medicinal plant Corydalis calliantha Long, which is used for the treatment of malaria, have been assessed. Four known alkaloids, protopine (1), scoulerine (2), Cheilanthifoline (3) and stylopine (4) are reported from this plant for the first time. The protopine alkaloid, protopine, and the tetrahydroprotoberine alkaloid, Cheilanthifoline, showed promising in vitro antiplasmodial activities against Plasmodium falciparum, both wild type (TM4) and multidrug resistant (K1) strains with IC(50) values in the range of 2.78-4.29 microM. Such activity had not been demonstrated previously for Cheilanthifoline. The results thus support, at a molecular level, the clinical use of this plant in the Bhutanese traditional medicine and identified Cheilanthifoline as a potential new antimalarial drug lead.
Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum.[Pubmed:26992921]
Arch Pharm Res. 2016 May;39(5):713-20.
A phytochemical investigation for the rhizome extract from Sinomenium acutum (Menispermaceae) resulted in the isolation of several active principles responsible for the anti-osteoclastogenic property of the extract, together with related isoquinoline alkaloids (1-13) including two new compounds, 1 and 2. Among isolated compounds, salutaridine (7), dauricumine (10), Cheilanthifoline (12), and dauriporphine (13) were observed to give significant inhibitions on receptor activator of nuclear factor-kappaB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts, respectively. The chemical structures of two newly isolated compounds, 1 and 2 were established as 8-demethoxycephatonine (1) and 7(R)-7,8-dihydrosinomenine (2), by spectroscopic analyses including 2D NMR experiments.
